# LB PHARMACEUTICALS INC — Form D

LB PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-27. The offering totals $443K, of which $443K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-08-27
- Form: D
- Accession: 0001691082-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $443K
- Amount sold: $443K
- Minimum investment: $10K
- Investors: 7
- Date of first sale: 2017-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320086

## Issuer

- Name: LB PHARMACEUTICALS INC
- CIK: 0001691082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 575 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: 212-605-0230

## Officers, directors & promoters (16)

| Name | Role | Location |
| --- | --- | --- |
| Mark Panoff | Executive Officer | New York, NY |
| Simon Basseyn | Director | New York, NY |
| CHEN YU | Director | PALO ALTO, CA |
| Rebecca Luse | Director | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Rajul Jain | Director | South San Francisco, CA |
| Ran Nussbaum | Director | New York, NY |
| Zachary Prensky | Director | New York, NY |
| Zachary Prensky | Executive Officer | New York, NY |
| Andrew Vaino | Executive Officer | New York, NY |
| Anna Eramo | Executive Officer | New York, NY |
| Marc Panoff | Executive Officer | New York, NY |
| Edmund Sullivan | Director | New York, NY |
| Vincent Grattan | Director | New York, NY |
| Piero Poli | Director | New York, NY |
| Lauren Stipp | Executive Officer | New York, NY |

## Other filings by this issuer (10)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-01-10](https://search.stillhousedata.com/formd/0001691082-24-000001) | D/A | $110.7M | $110.7M |
| [2023-09-21](https://search.stillhousedata.com/formd/0001691082-23-000004) | D | $110.7M | $70.7M |
| [2022-11-23](https://search.stillhousedata.com/formd/0001567619-22-020814) | D/A | $40.0M | $16.6M |
| [2022-11-01](https://search.stillhousedata.com/formd/0001567619-22-018986) | D | $10.0M | $6.9M |
| [2022-07-06](https://search.stillhousedata.com/formd/0001567619-22-013710) | D | — | $903K |
| [2020-09-01](https://search.stillhousedata.com/formd/0001567619-20-016229) | D | $10.0M | $4.6M |
| [2018-12-12](https://search.stillhousedata.com/formd/0001691082-18-000003) | D | $10.0M | $6.3M |
| [2018-05-29](https://search.stillhousedata.com/formd/0001691082-18-000001) | D | $750K | $330K |
| [2017-04-06](https://search.stillhousedata.com/formd/0001691082-17-000001) | D | $462K | $462K |
| [2016-12-15](https://search.stillhousedata.com/formd/0001691082-16-000001) | D | $1.0M | $969K |

## More

- [CIK 1691082 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1691082&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001691082-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.